Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 7:47 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 457–480 of 612 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: iron Clear all

Conditions: Parkinson Disease, REM Sleep Behavior Disorder, Healthy
Interventions: (11C)PE2I, Ioflupane; Drug
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 20 Years to 100 Years
Enrollment: 82 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Anaemia
Interventions: Daprodustat, Darbepoetin alfa, Iron therapy; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 99 Years
Enrollment: 312 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 36
States / cities: Anaheim, California • Cerritos, California • Escondido, California + 31 more

Conditions: Prostate Cancer, Bladder Cancer, Kidney Cancer
Interventions: Ferumoxytol, Magnetic Resonance Imaging (MRI); Drug · Diagnostic Test
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 99 Years
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Pulmonary Vein Stenosis
Interventions: Ferumoxytol; Drug
Lead sponsor: Children's Hospital of Philadelphia; Other
Eligibility: Up to 18 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Beta-Thalassemia
Interventions: ICL670, deferoxamine; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 2 Years and older
Enrollment: 595 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2003
U.S. locations: 7
States / cities: Los Angeles, California • Oakland, California • Stanford, California + 4 more

Conditions: Health, Subjective
Interventions: Experimental supplement, Placebo; Dietary Supplement
Lead sponsor: Auburn University; Other
Eligibility: 21 Years to 40 Years · Female only
Enrollment: 94 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Auburn, Alabama

Conditions: Iron Deficiency Anemia
Interventions: Ferric carboxymaltose; Drug
Lead sponsor: Sandoz; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 71 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Iron Deficiency
Interventions: BioFe Medical Food; Other
Lead sponsor: Sidero Bioscience, LLC; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 3
States / cities: Lansdale, Pennsylvania • Scottdale, Pennsylvania • Smithfield, Pennsylvania

Conditions: Pulmonary Embolism
Interventions: Ferumoxytol; Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years to 85 Years
Enrollment: 1 participant
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Anemia, Iron-Deficiency
Interventions: CSJ137, Placebo; Biological · Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 5
States / cities: San Diego, California • Lakewood, Colorado • Orlando, Florida + 2 more

Conditions: Anemia, Iron Deficiency
Interventions: IV iron; Drug
Lead sponsor: Sutter Gould Medical Foundation; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Modesto, California

Conditions: Iron Deficiency Anemia
Interventions: Non-fortified rice, Iron-fortified Rice; Other
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Iron Deficiency Anemia, Inflammatory Bowel Disease
Interventions: Intravenous iron sucrose, Oral ferrous sulfate; Drug
Lead sponsor: Wayne State University; Other
Eligibility: 12 Years to 17 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Iron Deficiency Anemia
Interventions: ferumoxytol; Drug
Lead sponsor: Dialysis Clinic, Inc.; Industry
Eligibility: Not listed
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: North Brunswick, New Jersey

Conditions: Iron Deficiency Anemia, Impaired Renal Function
Interventions: Ferric Carboxymaltose (FCM), Iron Sucrose (Venofer); Drug
Lead sponsor: American Regent, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 2,561 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Norristown, Pennsylvania

Conditions: Lung Carcinoma Metastatic in the Brain, Stage IV Lung Non-Small Cell Cancer AJCC v7
Interventions: Ferumoxytol, Laboratory Biomarker Analysis, Magnetic Resonance Imaging, Pembrolizumab; Drug · Other · Procedure + 1 more
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Autosomal Dominant Hypophosphatemic Rickets
Interventions: Iron; Dietary Supplement
Lead sponsor: Indiana University; Other
Eligibility: 25 Months and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Anemia
Interventions: Sodium Ferric Gluconate Complex in Sucrose.; Drug
Lead sponsor: Watson Pharmaceuticals; Industry
Eligibility: 2 Years to 16 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2005
U.S. locations: 10
States / cities: Birmingham, Alabama • Los Angeles, California • San Diego, California + 7 more

Conditions: Kidney Failure, Chronic, Anemia, Iron-Deficiency
Interventions: Sodium Ferric Gluconate and Iron sucrose; Drug
Lead sponsor: Watson Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2006
U.S. locations: 2
States / cities: Glendale, California • Shreveport, Louisiana

Conditions: Iron Deficiency Anemia
Interventions: Iron Sucrose; Drug
Lead sponsor: American Regent, Inc.; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: Norristown, Pennsylvania

Conditions: Iron Overload
Interventions: Serum Ferritin level, Serum Ferritin iron content, Urine Ferritin level, Urine ferritin iron content; Diagnostic Test
Lead sponsor: University of Utah; Other
Eligibility: 1 Year to 17 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Anemia, Iron Deficiency (Without Anemia), Iron Absorption
Interventions: marine-based heme iron; Dietary Supplement
Lead sponsor: Nutraceuticals Research Institute; Other
Eligibility: 21 Years to 42 Years · Female only
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Huntsville, Alabama

Conditions: Evaluation of Bioavailability of Supplemental Forms of Iron
Interventions: dietary iron supplementation; Dietary Supplement
Lead sponsor: University of Mary Hardin-Baylor; Other
Eligibility: 18 Years to 45 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Belton, Texas

Conditions: Multiple Sclerosis
Interventions: Feraheme, Gadolinium-based contrast; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 2
States / cities: Stanford, California

Search by objective public record fields.

Quantitative Mapping of Substantia Nigra Iron in Parkinson's Disease (Stages I-IV, REM Sleep Behavior Disorder) and Controls

Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat-in Incident Dialysis (ASCEND-ID)

Study of Ferumoxytol Enhanced MRI for Detecting Lymph Node Metastases in Prostate, Bladder, and Kidney Cancers

Calculating Wall Shear Stress in Infant Pulmonary Veins

Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood Transfusions

The Effects of a Multi-vitamin Supplement in Adult Females

A Study Comparing Two Ferric Carboxymaltose Formulations in Patients With Iron Deficiency Anemia

BioFe, Medical Food for the Dietary Management of Iron Deficiency

Ferumoxytol as a Contrast Agent for Pulmonary Magnetic Resonance Angiography

A Two-part Single- and Repeat-dose Study of CSJ137 in Anemic Chronic Hemodialysis Patients

A Randomized Study to Compare the Dosing Schedule of INFeD in Anemic Patients.

Pilot Study of the Effect of Iron Fortified Rice in Iron Deficient Anemic Women

IV Iron Sucrose vs Oral FeSO4 in Treating IDA in Pediatric IBD

Iron Indices and Intravenous Ferumoxytol: Time to Steady State

Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal Function

Pembrolizumab and Magnetic Resonance Imaging With Ferumoxytol in Treating Patients With Non-small Cell Lung Cancer and Brain Metastases

Iron Therapy for Autosomal Dominant Hypophosphatemic Rickets: A Pilot Project.

Study of the Safety and Efficacy of Ferrlecit® Maintenance Dosing in Pediatric Hemodialysis Patients

Effect of Two Iron Preparations on Protein in the Urine

Safety Assessment of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumoxytol (Feraheme) or Iron Dextran (INFed or Dexferrum)

The Iron Content of Ferritin in Serum and Urine of Children With High Serum Ferritin Levels

The Immediate and Long-term Effects of a Novel Marine-based Iron Supplement in Adult Females

Glycoprotein Matrix-Bound Iron Improves Iron Absorption

High-Field MRI Iron-Based Contrast-Enhanced Characterization of Multiple Sclerosis and Demyelinating Diseases